All posts in “Gen-Probe”

MPLN / Geneuity contributes to FDA approval of the Panther(TM) System

MPLN, through it’s Geneuity Clinical Research Services Division, participated in the instrument performance evaluations that contributed to the FDA approval of the Panther(TM) system for use with the APTIMA 2 Combo assay, particularly testing for the common sexually transmitted infections Chlamydia trachomatis andNeisseria gonorrhoeae. “It is a credit to the scores of talented and dedicated scientists and engineers who made it happen.  We believe that PANTHER will continue that revolution by bringing the power of fully-automated, sample to result capabilities to low- and medium- volume labs.,” said Carl Hull, Gene-Probe’s chairman and chief executive officer.